Welcome to our dedicated page for Cardinal Health news (Ticker: $CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cardinal Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cardinal Health's position in the market.
Cardinal Health (CAH) has announced an increase in its quarterly dividend to $0.5056 per share, payable on July 15, 2024, to shareholders of record as of July 1, 2024.
Cardinal Health reported third quarter fiscal year 2024 revenues of $54.9 billion, a 9% increase from the previous year. GAAP operating earnings were $367 million, with GAAP diluted EPS at $1.05. Non-GAAP operating earnings increased 10% to $666 million, and non-GAAP diluted EPS rose 20% to $2.08. The company raised its fiscal year 2024 non-GAAP EPS guidance to $7.30 to $7.40 and provided preliminary guidance for fiscal year 2025 of at least $7.50.